Trelegy gets FDA thumbs-up for asthma, becoming first triple-combo therapy in the US
One of GSK’s biggest blockbusters just got a whole new indication to play with.
Trelegy Ellipta received the green light from the FDA late Wednesday …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
